prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resectio. - right breast with axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of neoplastic cell nuclei. HER2 protein stained with HercepTestTM by DAKO. Positive reaction in invasive carcinoma cells. ( Score = 3+ ). Macroscopic description: Right breast sized 23 x 18 x 4 cm removed along with axillary tissues sized 12 x 8 x 3.5 cm and a skin flap of 21 x 11 cm. Weight. 700 g. Tumour sized 4.5 x 3.5 x 3 cm found on the boundary of outer quadrants, located 4.2 cm from the ouer boundary, 0.5 cm from. the base and 1.7 cm from the skin. Microscopic description: Carcinoma invasivum (partim signet ring cell carcinoma) - NHG2 (3+3+1/7 mitoses/10 HPF - visual area 0.55mm). Glandular tissue showing parenchymal atrophy. Axillary lymph nodes: Metastases et micrometastases carcinomatosae in lymphonodis (No XIV/XVI). Infiltratio capsulae lymphonodorum et. telae perinodalis. Emboliae carcinomatosae vasorum. Histopathological diagnosis: Carcinoma invasivum mammae dextrae. Metastases et micrometastases carcinomatosae in lymphonodis axillae (No XIV/XVI). (NHG2; pT2; pN3a). Final. diagnosis to be given after supplementary tests. Examination: Histopathological examination. page 2 / 2. Gender: F. Examination performed or. Examination result/Final Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. NHG2, pT2, pN3a. Invasive ductal carcinoma of the pT2, pN3a. Immunophenotype: CK7-, CK 5/6-, GCDFP-15-, E-cadherin+, PAS+. Compliance validated L,.

expanded version (tokens=948) : 
 The breast pathology report reveals the following information:

1. Histological Classification: The carcinoma type is invasive ductal carcinoma with a part-time signet ring cell carcinoma subtype identified. 

2. Receptor Status: The immunohistochemical examination shows that estrogen receptors are present in over 75 percent of neoplastic cell nuclei, and progesterone receptors are present in 10-75 percent of neoplastic cell nuclei. The HER2 protein is stained with HercepTestTM by DAKO with a positive reaction observed in invasive carcinoma cells, giving a score of 3+. 

3. Necrosis: There is no mention of any necrosis in the report.

4. Tumor Infiltrating Lymphocytes: The report does not mention the presence or absence of tumor-infiltrating lymphocytes.

5. Histological Grade: The histological grade assigned is NHG2, which means intermediate differentiation.

6. Nuclear Grade: The nuclear grade is also NHG2 and indicates intermediate differentiation.

7. Lymphovascular Invasion: The presence or absence of lymphovascular invasion is not mentioned in the report.

8. Calcification: The report does not mention any calcification.

9. Ancillary Testing Results: There is no mention of any other ancillary testing results in the report other than the immunohistochemical examination and the histological examination.

In summary, the breast pathology report revealed the patient has invasive ductal carcinoma with a signet ring cell carcinoma subtype.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1112) : 
 Report: The breast pathology examination revealed invasive ductal carcinoma with part-time signet-ring cell carcinoma. The tumors measured 4.5 x 3.5X 3 cm and showed intermediate nuclear differentiation (NHG2). Immunohistochemical examination determined estrogen and progesterone receptors are present in neoplastic cell nuclei, with a positive reaction for the HER2 protein. Micrometastases were discovered in axillary lymph nodes, with no mention of any necrosis, lymphovascular invasion, or calcification found. No other ancillary testing was done.

